Brief: Starpharma Withdraws Application For Marketing Of Spl7013 Nasal Spray In Australia
18/10/2024 01:53
Oct 18 (Reuters) - Starpharma Holdings Ltd SPL.AX :
* WITHDRAWN APPLICATION FOR MARKETING AUTHORISATION OF
SPL7013
NASAL SPRAY IN AUSTRALIA.
Further company coverage: SPL.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Starpharma Holdings
See all newsBrief: Starpharma Increases Stake In Petalion To 66% Securing Majority Ownership
Brief: Starpharma Seeks Trading Halt
Brief: Starpharma Holdings Appoints Russell Basser As Chair
Brief: Starpharma Says Fully Underwritten Entitlement Offer To Raise A$32 MLN
Australia's Starpharma slumps to 1-1/2-month low on discounted fund raising